Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (673)	12/14/1997 3:36:00 PM
From: Cisco	Respond to of 1894

Frank, EXACTLY! That is the main reason I own this stock. Did you notice that if ACMI traded at the average price/sales ratio of the other four you listed, then it would be trading at $16.44 a share! Cisco

To: Frank Buck who wrote (673)	12/14/1997 10:56:00 PM
From: Cisco	Read Replies (1) \| Respond to of 1894

Frank, There is a new group out that plans to keep Pap smears in the public eye during 1998. How this will affect companies such as AccuMed is yet to be seen. Certianly it can't hurt. The National Cervical Cancer Coalition's mission is to enhance awareness of the traditional Pap smear, new technologies and reimbursement issues facing cervical cancer screening. cytopathnet.org I wonder if AccuMed has joined the coalition? Cisco